Shopping Cart
Total:

$0.00

Items:

0

Checkout View Cart
Your cart is empty
Keep Shopping

Long-Term CAR-T Results in Lymphoma Confirm Early Promise



(MedPage Today) — Ten years after receiving a single dose of CD19-targeted CAR T-cell therapy, almost a third of patients with aggressive lymphomas and no treatment options remained lymphoma free, updated results from a landmark trial showed…



Source link

0
Show Comments (0) Hide Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments